News

Sant Pau administrates a new CAR-T immunotherapy drug, self-produced, against B-cell lymphomas

The Research Institute of the Hospital de la Santa Creu i Sant Pau - IIB Sant Pau has developed a new CAR-T 19 immunotherapy drug that has just begun to be administered, as part of a clinical trial, t...

A new blood marker indicates inflammation in the carotid plaque and the risk of stroke recurrence

Inflammation of the carotid plaque is an important factor in the risk of recurrent stroke in patients with carotid artery disease. A study led by Dr. Vicenta Llorente, coordinator of the Lipids and Ca...

Using sensors to monitor inhalers improves adherence to asthma and COPD treatment

Electronic inhaler monitoring devices can significantly improve patient adherence to inhaled therapy in adults with asthma or chronic obstructive pulmonary disease (COPD), according to a study by rese...

INNOPAU program kicks off to promote innovative culture in IIB Sant Pau

This week marked the start of the INNOPAU program, the idea incubator of IB Sant Pau, which aims to promote an innovation culture and provide value-added tools within the IIB Sant Pau ecosystem. This...

Let’s discover… the Confocal Microscopy Platform

The Confocal Microscopy Platform of the Research Institute of the Hospital de la Santa Creu i Sant Pau – IIB Sant Pau, coordinated by Dr. Esther Peña Sendra and in collaboration with the platform's...